A triple-drug therapy for pancreatic cancer has shown promise in early animal tests, pointing to a potential new treatment for a disease with a notoriously low survival rate.
Considered one of the deadliest common cancers, pancreatic cancer has…
Continue Reading
News Source: www.livescience.com

Leave a Reply